These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 28370373

  • 1. Association between Survival Time and Changes in NT-proBNP in Cats Treated for Congestive Heart Failure.
    Pierce KV, Rush JE, Freeman LM, Cunningham SM, Yang VK.
    J Vet Intern Med; 2017 May; 31(3):678-684. PubMed ID: 28370373
    [Abstract] [Full Text] [Related]

  • 2. Utility of plasma N-terminal pro-brain natriuretic peptide (NT-proBNP) to distinguish between congestive heart failure and non-cardiac causes of acute dyspnea in cats.
    Fox PR, Oyama MA, Reynolds C, Rush JE, DeFrancesco TC, Keene BW, Atkins CE, Macdonald KA, Schober KE, Bonagura JD, Stepien RL, Kellihan HB, Nguyenba TP, Lehmkuhl LB, Lefbom BK, Moise NS, Hogan DF.
    J Vet Cardiol; 2009 May; 11 Suppl 1():S51-61. PubMed ID: 19394287
    [Abstract] [Full Text] [Related]

  • 3. Multicenter evaluation of plasma N-terminal probrain natriuretic peptide (NT-pro BNP) as a biochemical screening test for asymptomatic (occult) cardiomyopathy in cats.
    Fox PR, Rush JE, Reynolds CA, Defrancesco TC, Keene BW, Atkins CE, Gordon SG, Schober KE, Bonagura JD, Stepien RL, Kellihan HB, Macdonald KA, Lehmkuhl LB, Nguyenba TP, Sydney Moise N, Lefbom BK, Hogan DF, Oyama MA.
    J Vet Intern Med; 2011 May; 25(5):1010-6. PubMed ID: 21985136
    [Abstract] [Full Text] [Related]

  • 4. Assessment of a bedside test for N-terminal pro B-type natriuretic peptide (NT-proBNP) to differentiate cardiac from non-cardiac causes of pleural effusion in cats.
    Wurtinger G, Henrich E, Hildebrandt N, Wiedemann N, Schneider M, Hassdenteufel E.
    BMC Vet Res; 2017 Dec 20; 13(1):394. PubMed ID: 29262821
    [Abstract] [Full Text] [Related]

  • 5. Assessment of circulating N-terminal pro B-type natriuretic peptide concentration to differentiate between cardiac from noncardiac causes of pleural effusion in cats.
    Hassdenteufel E, Henrich E, Hildebrandt N, Stosic A, Schneider M.
    J Vet Emerg Crit Care (San Antonio); 2013 Dec 20; 23(4):416-22. PubMed ID: 23859335
    [Abstract] [Full Text] [Related]

  • 6. Utility of measuring plasma N-terminal pro-brain natriuretic peptide in detecting hypertrophic cardiomyopathy and differentiating grades of severity in cats.
    Wess G, Daisenberger P, Mahling M, Hirschberger J, Hartmann K.
    Vet Clin Pathol; 2011 Jun 20; 40(2):237-44. PubMed ID: 21434959
    [Abstract] [Full Text] [Related]

  • 7. Assessment of the responsiveness of the Cats' Assessment Tool for Cardiac Health (CATCH) Questionnaire.
    Rush JE, Roderick KV, Freeman LM, Cunningham SM, Yang VK, Bulmer BJ, Antoon KN.
    J Vet Cardiol; 2015 Dec 20; 17 Suppl 1():S341-8. PubMed ID: 26776591
    [Abstract] [Full Text] [Related]

  • 8. The effect of atenolol on NT-proBNP and troponin in asymptomatic cats with severe left ventricular hypertrophy because of hypertrophic cardiomyopathy: a pilot study.
    Jung SW, Kittleson MD.
    J Vet Intern Med; 2011 Dec 20; 25(5):1044-9. PubMed ID: 21781160
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of point-of-care thoracic ultrasound and NT-proBNP for the diagnosis of congestive heart failure in cats with respiratory distress.
    Ward JL, Lisciandro GR, Ware WA, Viall AK, Aona BD, Kurtz KA, Reina-Doreste Y, DeFrancesco TC.
    J Vet Intern Med; 2018 Sep 20; 32(5):1530-1540. PubMed ID: 30216579
    [Abstract] [Full Text] [Related]

  • 10. Effect of NT-pro-BNP assay on accuracy and confidence of general practitioners in diagnosing heart failure or respiratory disease in cats with respiratory signs.
    Singletary GE, Rush JE, Fox PR, Stepien RL, Oyama MA.
    J Vet Intern Med; 2012 Sep 20; 26(3):542-6. PubMed ID: 22458368
    [Abstract] [Full Text] [Related]

  • 11. N-Terminal Pro-B-Type Natriuretic Peptide (NT-proBNP) Measurements Until a 30% Reduction Is Attained During Acute Decompensated Heart Failure Admissions and Comparison With Discharge NT-proBNP Levels: Implications for In-Hospital Guidance of Treatment.
    Stienen S, Salah K, Dickhoff C, Carubelli V, Metra M, Magrini L, Di Somma S, Tijssen JP, Pinto YM, Kok WE.
    J Card Fail; 2015 Nov 20; 21(11):930-4. PubMed ID: 26216495
    [Abstract] [Full Text] [Related]

  • 12. Cardiovascular-renal axis disorder and acute-phase proteins in cats with congestive heart failure caused by primary cardiomyopathy.
    Liu M, Köster LS, Fosgate GT, Chadwick CC, Sanz-González Í, Eckersall PD, Wotton PR, French AT.
    J Vet Intern Med; 2020 May 20; 34(3):1078-1090. PubMed ID: 32395893
    [Abstract] [Full Text] [Related]

  • 13. Relationship of plasma N-terminal pro-brain natriuretic peptide concentrations to heart failure classification and cause of respiratory distress in dogs using a 2nd generation ELISA assay.
    Fox PR, Oyama MA, Hezzell MJ, Rush JE, Nguyenba TP, DeFrancesco TC, Lehmkuhl LB, Kellihan HB, Bulmer B, Gordon SG, Cunningham SM, MacGregor J, Stepien RL, Lefbom B, Adin D, Lamb K.
    J Vet Intern Med; 2015 Jan 20; 29(1):171-9. PubMed ID: 25308881
    [Abstract] [Full Text] [Related]

  • 14. [Predictive value of admission amino-terminal pro-B-type natriuretic peptide on in-hospital mortality in patients with decompensated heart failure].
    Wei BQ, Yang YJ, Zhang J, Dou KF, Zhang YH, Huang XH, Kang LM, Zhang CL, Gu Q, Gao X, Yang YM, Dai Y, Yu LT, Zhang HM, Lü R.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Jun 20; 37(6):481-5. PubMed ID: 19927625
    [Abstract] [Full Text] [Related]

  • 15. Assessment of the diagnostic accuracy of circulating natriuretic peptide concentrations to distinguish between cats with cardiac and non-cardiac causes of respiratory distress.
    Connolly DJ, Soares Magalhaes RJ, Fuentes VL, Boswood A, Cole G, Boag A, Syme HM.
    J Vet Cardiol; 2009 May 20; 11 Suppl 1():S41-50. PubMed ID: 19394286
    [Abstract] [Full Text] [Related]

  • 16. Effect of prespecified therapy escalation on plasma NT-proBNP concentrations in dogs with stable congestive heart failure due to myxomatous mitral valve disease.
    Hezzell MJ, Block CL, Laughlin DS, Oyama MA.
    J Vet Intern Med; 2018 Sep 20; 32(5):1509-1516. PubMed ID: 30216549
    [Abstract] [Full Text] [Related]

  • 17. Long-term results of intensified, N-terminal-pro-B-type natriuretic peptide-guided versus symptom-guided treatment in elderly patients with heart failure: five-year follow-up from TIME-CHF.
    Sanders-van Wijk S, Maeder MT, Nietlispach F, Rickli H, Estlinbaum W, Erne P, Rickenbacher P, Peter M, Pfisterer MP, Brunner-La Rocca HP, TIME-CHF Investigators.
    Circ Heart Fail; 2014 Jan 20; 7(1):131-9. PubMed ID: 24352403
    [Abstract] [Full Text] [Related]

  • 18. Risk stratification with the use of serial N-terminal pro-B-type natriuretic peptide measurements during admission and early after discharge in heart failure patients: post hoc analysis of the PRIMA study.
    Eurlings LW, Sanders-van Wijk S, van Kraaij DJ, van Kimmenade R, Meeder JG, Kamp O, van Dieijen-Visser MP, Tijssen JG, Brunner-La Rocca HP, Pinto YM.
    J Card Fail; 2014 Dec 20; 20(12):881-90. PubMed ID: 25175696
    [Abstract] [Full Text] [Related]

  • 19. Plasma atrial natriuretic peptide and N-terminal pro B-type natriuretic peptide concentrations in dogs with right-sided congestive heart failure.
    Kanno N, Hori Y, Hidaka Y, Chikazawa S, Kanai K, Hoshi F, Itoh N.
    J Vet Med Sci; 2016 May 03; 78(4):535-42. PubMed ID: 26607133
    [Abstract] [Full Text] [Related]

  • 20. [Prognostic value of N-terminal-pro-brain natriuretic peptide on admission in patients with chronic heart failure].
    Wang F, Li W, Huang J, Wang L, Bian WY, Pang HM, Wang Y, Xu ZM, Li YS.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Jan 03; 34(1):28-32. PubMed ID: 16626545
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.